Investors In Avanir Cheer As Piper Jaffray Lifts Target On Stock Sharply From $6 To $13

Shares of Avanir Pharma (NASDAQ: AVNR ) have rallied more than 5 percent Monday afternoon following some bullish comments and a raise price target from Piper Jaffray's Charles Duncan earlier. Avanir shares had traded up as much as 13 percent in the pre-market session. The analyst more than doubled his